Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers

NCT05006378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-02-10

No results posted yet for this study

Summary

Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized, placebo-controlled complete crossover study will investigate the impact of chamomile ingestion on coagulation.

Conditions

  • Coagulation Disorder

Interventions

DIETARY_SUPPLEMENT

Chamomile Tea

Chamomile tea bags consumed by subjects as described in study arms section.

DIETARY_SUPPLEMENT

Chamomile Extract Capsule

Chamomile extract capsules consumed by subjects as described in "Experimental: Chamomile Extract Capsule" study arms section.

DIETARY_SUPPLEMENT

Placebo Capsule

Placebo capsules consumed by subjects as described in "Placebo Comparator" study arms section.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2022-01-19
Completion
2022-01-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006378 on ClinicalTrials.gov